New drugs take aim at one of cancerβs deadliest mutations
Nature, Published online: 07 April 2026; doi:10.1038/d41586-026-01016-7
Mutations in the KRAS protein were once deemed βundruggableβ. Today, various approaches are in the pipeline.Nature, Published online: 07 April 2026; doi:10.1038/d41586-026-01016-7
Mutations in the KRAS protein were once deemed βundruggableβ. Today, various approaches are in the pipeline.Nature, Published online: 07 April 2026; doi:10.1038/d41586-026-01024-7
A burgeoning field is launching its first clinical trial to find out whether dialling back cell development can safely refresh aged tissues and organs.